Grantham, Mayo, Van Otterloo & Co (GMO)’s Core & Main CNM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
– Sell
-7,688
Closed -$371K – 628
2025
Q1
$371K Buy
7,688
+3,324
+76% +$172K ﹤0.01% 563
2024
Q4
$222K Buy
+4,364
New +$206K ﹤0.01% 557
2024
Q3
– Sell
-6,658
Closed -$326K – 564
2024
Q2
$326K Sell
6,658
-26,529
-80% -$1.47M ﹤0.01% 475
2024
Q1
$1.9M Buy
+33,187
New +$1.52M 0.01% 367

Other funds holding CNM

Grantham, Mayo, Van Otterloo & Co (GMO)'s CNM Position: Q2 2025 in Review

Grantham, Mayo, Van Otterloo & Co (GMO) sold out of Core & Main (CNM) in Q2 2025, closing a stake of 7,688 shares — an estimated $371K sold.

Grantham, Mayo, Van Otterloo & Co (GMO) first reported a position in CNM in Q1 2024 and held it in 4 quarters. The position peaked at $1.9M in Q1 2024. 447 funds tracked by Wall St. Rank hold CNM as of Q2 2025.

  • Grantham, Mayo, Van Otterloo & Co (GMO) reported no remaining Core & Main position as of Q2 2025 after selling out during the quarter.
  • Grantham, Mayo, Van Otterloo & Co (GMO) sold 7,688 Core & Main shares in Q2 2025, an estimated $371K.
  • Grantham, Mayo, Van Otterloo & Co (GMO) first reported a position in Core & Main in Q1 2024 and held it in 4 quarters.
  • Grantham, Mayo, Van Otterloo & Co (GMO)'s Core & Main position peaked at $1.9M in Q1 2024.
  • 447 funds tracked by Wall St. Rank held Core & Main as of Q2 2025.

Based on Grantham, Mayo, Van Otterloo & Co (GMO)'s 13F filing for Q2 2025, filed 13 Aug 2025.